| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
|
Lundgren, Christine
|
|
2019
|
178 |
2 |
p. 459-467
|
article
|
| 2 |
Allelic modification of breast cancer risk in women with an NBN mutation
|
Rusak, Bogna
|
|
2019
|
178 |
2 |
p. 427-431
|
article
|
| 3 |
A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy
|
Robinson, Andrew
|
|
2019
|
178 |
2 |
p. 337-345
|
article
|
| 4 |
A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients
|
Arnaout, Angel
|
|
2019
|
178 |
2 |
p. 327-335
|
article
|
| 5 |
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases
|
Liu, Zhe-Bin
|
|
2019
|
178 |
2 |
p. 251-261
|
article
|
| 6 |
Differences in breast cancer outcomes amongst Black US-born and Caribbean-born immigrants
|
Barreto-Coelho, Priscila
|
|
2019
|
178 |
2 |
p. 433-440
|
article
|
| 7 |
Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer
|
Hida, Akira I.
|
|
2019
|
178 |
2 |
p. 283-294
|
article
|
| 8 |
Effect of early adverse events resulting in ado-trastuzumab emtansine dose adjustments on survival outcomes of HER2+ advanced breast cancer patients
|
Tang, Ethan
|
|
2019
|
178 |
2 |
p. 473-477
|
article
|
| 9 |
Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence
|
Lai, Chi Peng Timothy
|
|
2019
|
178 |
2 |
p. 295-305
|
article
|
| 10 |
Exploratory biomarker analysis from a phase II clinical trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine for HER2-negative metastatic breast cancer patients (KCSG BR13-11)
|
Kim, Ji-Yeon
|
|
2019
|
178 |
2 |
p. 367-377
|
article
|
| 11 |
Gene expression analysis to detect disseminated tumor cells in the bone marrow of triple-negative breast cancer patients predicts metastatic relapse
|
Siddappa, Chidananda M.
|
|
2019
|
178 |
2 |
p. 317-325
|
article
|
| 12 |
Genomic landscape of ductal carcinoma in situ and association with progression
|
Lin, Chieh-Yu
|
|
2019
|
178 |
2 |
p. 307-316
|
article
|
| 13 |
HER2 double-equivocal breast cancer in Chinese patients: a high concordance of HER2 status between different blocks from the same tumor
|
Liu, Yuanyuan
|
|
2019
|
178 |
2 |
p. 275-281
|
article
|
| 14 |
Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes
|
Viale, Giuseppe
|
|
2019
|
178 |
2 |
p. 451-458
|
article
|
| 15 |
Letter regarding Sopik V et al. entitled “Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ”
|
Wang, Xiangyu
|
|
2019
|
178 |
2 |
p. 481-482
|
article
|
| 16 |
Long-term outcome with targeted therapy in advanced/metastatic HER2-positive breast cancer: The Royal Marsden experience
|
Battisti, Nicolò Matteo Luca
|
|
2019
|
178 |
2 |
p. 401-408
|
article
|
| 17 |
Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database
|
Liu, Yan-ling
|
|
2019
|
178 |
2 |
p. 379-388
|
article
|
| 18 |
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
|
He, Jichao
|
|
2019
|
178 |
2 |
p. 263-274
|
article
|
| 19 |
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination
|
Swain, Sandra M.
|
|
2019
|
178 |
2 |
p. 389-399
|
article
|
| 20 |
Phase II randomized controlled trial of hypnosis versus progressive muscle relaxation for body image after breast or gynecologic cancer
|
Barton, Debra L.
|
|
2019
|
178 |
2 |
p. 357-365
|
article
|
| 21 |
Precision medicine: PI3K targeting in advanced breast cancer
|
Rocca, Andrea
|
|
2019
|
178 |
2 |
p. 479
|
article
|
| 22 |
Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients
|
Arnaout, Angel
|
|
2019
|
178 |
2 |
p. 347-356
|
article
|
| 23 |
Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression
|
Sorscher, Steven
|
|
2019
|
178 |
2 |
p. 469-471
|
article
|
| 24 |
Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study
|
Mannu, Gurdeep S.
|
|
2019
|
178 |
2 |
p. 409-418
|
article
|
| 25 |
Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system
|
Eaglehouse, Yvonne L.
|
|
2019
|
178 |
2 |
p. 441-450
|
article
|
| 26 |
Utilization, duration, and outcomes of neoadjuvant endocrine therapy in the United States
|
Pariser, Ashley C.
|
|
2019
|
178 |
2 |
p. 419-426
|
article
|
Journal description